Biomarker-directed precision oncology of pembrolizumab-based combination therapy for non small cell lung cancer: Phase II KEYNOTE-495/KeyImPaCT study Meeting Abstract
| Authors: | Gutierrez, M.; Hellmann, M. D.; Gubens, M. A.; Aggarwal, C.; Tan, D. S. W.; Felip, E.; Chiu, J. W. Y.; Lee, J. S.; Yang, J. C. H.; Garon, E. B.; Basso, A.; Ma, H.; Fong, L.; Snyder, A.; Yuan, J. D.; Herbst, R. S. |
| Abstract Title: | Biomarker-directed precision oncology of pembrolizumab-based combination therapy for non small cell lung cancer: Phase II KEYNOTE-495/KeyImPaCT study |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 505s |
| Language: | English |
| ACCESSION: | WOS:000487345803462 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS9117 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS9117 -- Source: Wos |
